Kent Fagan is a notable inventor based in Centennial, CO (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified cyclic nucleotide gated ion channels. With a total of 2 patents, his work has implications for various scientific and medical applications.

Latest Patents

Fagan's latest patents include innovations in modified cyclic nucleotide gated (CNG) channels. The first patent focuses on providing modified CNG channels that exhibit increased sensitivity and specificity for cAMP, compared to wild-type CNG channels. Additionally, this invention removes regulation by Ca-calmodulin in the modified CNG channels. It also introduces convenient optical methods for detecting changes in cAMP, leveraging the permeability of the channel. Furthermore, electrophysiological methods are included in this patent. The second patent similarly addresses modified CNG channels, reiterating the increased sensitivity and specificity for cAMP and the removal of Ca-calmodulin regulation, along with the same optical and electrophysiological methods.

Career Highlights

Kent Fagan is affiliated with the University of Colorado, where he continues to advance research in his field. His work has garnered attention for its innovative approach to ion channel modification, which could lead to breakthroughs in understanding cellular signaling mechanisms.

Collaborations

Fagan has collaborated with esteemed colleagues such as Jeffrey W. Karpen and Thomas C. Rich, contributing to a rich environment of research and innovation.

Conclusion

Kent Fagan's contributions to the field of cyclic nucleotide gated ion channels highlight his role as a significant inventor. His patents reflect a commitment to advancing scientific knowledge and technology.